Institutional Ownership Medicenna Therapeutics Corp. (MDNA)
This table provides information about the institutional ownership of Medicenna Therapeutics Corp. (MDNA). We have compiled data on the 3 institutions that hold shares in the stock, with a total of 863,386 shares, which have been reported (via 13F filing form) to have a value of $267,000.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Empery Asset Management, LP
New York, NY |
Nov 14, 2022 Q3 2022 |
589,316
shares
|
$182,687
2.91% of portfolio
|
Q3 2022
New holding
|
|
Act Capital Management, LLC
Wayne, PA |
Nov 03, 2022 Q3 2022 |
149,070
shares
|
$46,211
0.17% of portfolio
|
Q2 2022
Reduced 2.25%
|
|
Org Partners LLC
Roanoke, IN |
Oct 11, 2024 Q3 2024 |
125,000
shares
|
$38,750
0.01% of portfolio
|
Q3 2024
Added 25.0%
|